What should a nurse monitor for after administering intravenous albumin due to increased blood volume?

Monitoring for increased bleeding after administering intravenous albumin is critical due to the potential effects of fluid volume expansion on hemodynamics and the risk of dilutional coagulopathy. When albumin is infused, it increases the plasma volume, which can lead to hemodilution and may affect coagulation factors. This can result in a decreased ability to form clots, potentially increasing the risk of bleeding, especially in patients who are already susceptible to bleeding disorders or are on anticoagulation therapy.

While monitoring for allergic reactions is always a consideration with any intravenous medication, it is not specifically related to the effects of increased blood volume from albumin infusion. Similarly, monitoring hemoglobin levels is important but would typically remain stable immediately following albumin administration and may not provide insight into bleeding risk as effectively as monitoring clotting parameters. Monitoring glucose levels is not directly related to albumin administration and thus is not a primary concern in this context.